Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Complement Deficiencies Result in Surrogate Pathways of Complement Activation in Novel Polygenic Lupus-like Models of Kidney Injury.

Skopelja-Gardner S, Colonna L, Hermanson P, Sun X, Tanaka L, Tai J, Nguyen Y, Snyder JM, Alpers CE, Hudkins KL, Salant DJ, Peng Y, Elkon KB.

J Immunol. 2020 Apr 1. pii: ji1901473. doi: 10.4049/jimmunol.1901473. [Epub ahead of print]

PMID:
32238460
2.

Loss of Roundabout Guidance Receptor 2 (Robo2) in Podocytes Protects Adult Mice from Glomerular Injury by Maintaining Podocyte Foot Process Structure.

Pisarek-Horowitz A, Fan X, Kumar S, Rasouly HM, Sharma R, Chen H, Coser K, Bluette CT, Hirenallur-Shanthappa D, Anderson SR, Yang H, Beck LH Jr, Bonegio RG, Henderson JM, Berasi SP, Salant DJ, Lu W.

Am J Pathol. 2020 Apr;190(4):799-816. doi: 10.1016/j.ajpath.2019.12.009. Epub 2020 Mar 24.

PMID:
32220420
3.

Refining Our Understanding of the PLA2R-Antibody Response in Primary Membranous Nephropathy: Looking Forward, Looking Back.

Beck LH Jr, Salant DJ.

J Am Soc Nephrol. 2020 Jan;31(1):8-11. doi: 10.1681/ASN.2019111195. Epub 2019 Dec 16. No abstract available.

PMID:
31871252
4.

Does Epitope Spreading Influence Responsiveness to Rituximab in PLA2R-Associated Membranous Nephropathy?

Salant DJ.

Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1122-1124. doi: 10.2215/CJN.07300619. Epub 2019 Jul 24. No abstract available.

PMID:
31340980
5.

Towards minimally-invasive, quantitative assessment of chronic kidney disease using optical spectroscopy.

Belghasem ME, A'amar O, Roth D, Walker J, Arinze N, Richards SM, Francis JM, Salant DJ, Chitalia VC, Bigio IJ.

Sci Rep. 2019 May 9;9(1):7168. doi: 10.1038/s41598-019-43684-8.

6.

Activation of fibroblastic reticular cells in kidney lymph node during crescentic glomerulonephritis.

Kasinath V, Yilmam OA, Uehara M, Jiang L, Ordikhani F, Li X, Salant DJ, Abdi R.

Kidney Int. 2019 Feb;95(2):310-320. doi: 10.1016/j.kint.2018.08.040. Epub 2018 Dec 3.

7.

Unmet challenges in membranous nephropathy.

Salant DJ.

Curr Opin Nephrol Hypertens. 2019 Jan;28(1):70-76. doi: 10.1097/MNH.0000000000000459. Review.

8.

Deep pockets are not necessarily a good thing in membranous nephropathy: evidence for a modifier allele.

Beck LH Jr, Salant DJ.

Kidney Int. 2018 Nov;94(5):855-857. doi: 10.1016/j.kint.2018.07.010.

PMID:
30348302
9.

Krüppel-like factor 4 is a negative regulator of STAT3-induced glomerular epithelial cell proliferation.

Estrada CC, Paladugu P, Guo Y, Pace J, Revelo MP, Salant DJ, Shankland SJ, D'Agati VD, Mehrotra A, Cardona S, Bialkowska AB, Yang VW, He JC, Mallipattu SK.

JCI Insight. 2018 Jun 21;3(12). pii: 98214. doi: 10.1172/jci.insight.98214. eCollection 2018 Jun 21.

10.

Neutrophil exocytosis induces podocyte cytoskeletal reorganization and proteinuria in experimental glomerulonephritis.

Caster DJ, Korte EA, Tan M, Barati MT, Tandon S, Creed TM, Salant DJ, Hata JL, Epstein PN, Huang H, Powell DW, McLeish KR.

Am J Physiol Renal Physiol. 2018 Sep 1;315(3):F595-F606. doi: 10.1152/ajprenal.00039.2018. Epub 2018 May 23.

11.

Association of Pathological Fibrosis With Renal Survival Using Deep Neural Networks.

Kolachalama VB, Singh P, Lin CQ, Mun D, Belghasem ME, Henderson JM, Francis JM, Salant DJ, Chitalia VC.

Kidney Int Rep. 2018 Jan 11;3(2):464-475. doi: 10.1016/j.ekir.2017.11.002. eCollection 2018 Mar.

12.

LDL Receptor-Related Protein 2 (Megalin) as a Target Antigen in Human Kidney Anti-Brush Border Antibody Disease.

Larsen CP, Trivin-Avillach C, Coles P, Collins AB, Merchant M, Ma H, Wilkey DW, Ambruzs JM, Messias NC, Cossey LN, Rosales IA, Wooldridge T, Walker PD, Colvin RB, Klein J, Salant DJ, Beck LH Jr.

J Am Soc Nephrol. 2018 Feb;29(2):644-653. doi: 10.1681/ASN.2017060664. Epub 2017 Oct 26.

13.

ABIN1 Determines Severity of Glomerulonephritis via Activation of Intrinsic Glomerular Inflammation.

Korte EA, Caster DJ, Barati MT, Tan M, Zheng S, Berthier CC, Brosius FC 3rd, Vieyra MB, Sheehan RM, Kosiewicz M, Wysoczynski M, Gaffney PM, Salant DJ, McLeish KR, Powell DW.

Am J Pathol. 2017 Dec;187(12):2799-2810. doi: 10.1016/j.ajpath.2017.08.018. Epub 2017 Sep 19.

14.

Retinoic acid improves nephrotoxic serum-induced glomerulonephritis through activation of podocyte retinoic acid receptor α.

Dai Y, Chen A, Liu R, Gu L, Sharma S, Cai W, Salem F, Salant DJ, Pippin JW, Shankland SJ, Moeller MJ, Ghyselinck NB, Ding X, Chuang PY, Lee K, He JC.

Kidney Int. 2017 Dec;92(6):1444-1457. doi: 10.1016/j.kint.2017.04.026. Epub 2017 Jul 27.

15.

Thrombotic Microangiopathy: A Multidisciplinary Team Approach.

Gordon CE, Chitalia VC, Sloan JM, Salant DJ, Coleman DL, Quillen K, Ravid K, Francis JM.

Am J Kidney Dis. 2017 Nov;70(5):715-721. doi: 10.1053/j.ajkd.2017.05.017. Epub 2017 Jul 15.

PMID:
28720207
16.

SLIT2/ROBO2 signaling pathway inhibits nonmuscle myosin IIA activity and destabilizes kidney podocyte adhesion.

Fan X, Yang H, Kumar S, Tumelty KE, Pisarek-Horowitz A, Rasouly HM, Sharma R, Chan S, Tyminski E, Shamashkin M, Belghasem M, Henderson JM, Coyle AJ, Salant DJ, Berasi SP, Lu W.

JCI Insight. 2016 Nov 17;1(19):e86934. doi: 10.1172/jci.insight.86934.

17.

Loss of Zeb2 in mesenchyme-derived nephrons causes primary glomerulocystic disease.

Rasouly HM, Kumar S, Chan S, Pisarek-Horowitz A, Sharma R, Xi QJ, Nishizaki Y, Higashi Y, Salant DJ, Maas RL, Lu W.

Kidney Int. 2016 Dec;90(6):1262-1273. doi: 10.1016/j.kint.2016.06.037. Epub 2016 Aug 31.

18.

An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy.

Hoxha E, Beck LH Jr, Wiech T, Tomas NM, Probst C, Mindorf S, Meyer-Schwesinger C, Zahner G, Stahl PR, Schöpper R, Panzer U, Harendza S, Helmchen U, Salant DJ, Stahl RA.

J Am Soc Nephrol. 2017 Feb;28(2):520-531. doi: 10.1681/ASN.2016010050. Epub 2016 Jul 19.

19.

The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated Hypercholesterolemia.

Haas ME, Levenson AE, Sun X, Liao WH, Rutkowski JM, de Ferranti SD, Schumacher VA, Scherer PE, Salant DJ, Biddinger SB.

Circulation. 2016 Jul 5;134(1):61-72. doi: 10.1161/CIRCULATIONAHA.115.020912.

20.

Membranous Nephropathy: A Journey From Bench to Bedside.

Francis JM, Beck LH Jr, Salant DJ.

Am J Kidney Dis. 2016 Jul;68(1):138-47. doi: 10.1053/j.ajkd.2016.01.030. Epub 2016 Apr 13. Review.

21.

Pregnancy in a Patient With Primary Membranous Nephropathy and Circulating Anti-PLA2R Antibodies: A Case Report.

Al-Rabadi L, Ayalon R, Bonegio RG, Ballard JE, Fujii AM, Henderson JM, Salant DJ, Beck LH Jr.

Am J Kidney Dis. 2016 May;67(5):775-8. doi: 10.1053/j.ajkd.2015.10.031. Epub 2015 Dec 29.

22.

Shp2 Associates with and Enhances Nephrin Tyrosine Phosphorylation and Is Necessary for Foot Process Spreading in Mouse Models of Podocyte Injury.

Verma R, Venkatareddy M, Kalinowski A, Patel SR, Salant DJ, Garg P.

Mol Cell Biol. 2015 Dec 7;36(4):596-614. doi: 10.1128/MCB.00956-15. Print 2016 Feb 15.

23.

Podocyte Expression of B7-1/CD80: Is it a Reliable Biomarker for the Treatment of Proteinuric Kidney Diseases with Abatacept?

Salant DJ.

J Am Soc Nephrol. 2016 Apr;27(4):963-5. doi: 10.1681/ASN.2015080947. Epub 2015 Sep 23. No abstract available.

24.

IL-6 Trans-Signaling Drives Murine Crescentic GN.

Braun GS, Nagayama Y, Maruta Y, Heymann F, van Roeyen CR, Klinkhammer BM, Boor P, Villa L, Salant DJ, Raffetseder U, Rose-John S, Ostendorf T, Floege J.

J Am Soc Nephrol. 2016 Jan;27(1):132-42. doi: 10.1681/ASN.2014111147. Epub 2015 Jun 3.

25.

Anti-phospholipase A₂ receptor antibodies in recurrent membranous nephropathy.

Kattah A, Ayalon R, Beck LH Jr, Sethi S, Sandor DG, Cosio FG, Gandhi MJ, Lorenz EC, Salant DJ, Fervenza FC.

Am J Transplant. 2015 May;15(5):1349-59. doi: 10.1111/ajt.13133. Epub 2015 Mar 12.

26.

Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.

Tomas NM, Beck LH Jr, Meyer-Schwesinger C, Seitz-Polski B, Ma H, Zahner G, Dolla G, Hoxha E, Helmchen U, Dabert-Gay AS, Debayle D, Merchant M, Klein J, Salant DJ, Stahl RAK, Lambeau G.

N Engl J Med. 2014 Dec 11;371(24):2277-2287. doi: 10.1056/NEJMoa1409354. Epub 2014 Nov 13.

27.

Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study.

Timmermans SA, Damoiseaux JG, Heerings-Rewinkel PT, Ayalon R, Beck LH Jr, Schlumberger W, Salant DJ, van Paassen P, Tervaert JW; Limburg Renal Registry.

Am J Clin Pathol. 2014 Jul;142(1):29-34. doi: 10.1309/AJCP8QMOY5GLRSFP.

PMID:
24926082
28.

Membranous nephropathy: from models to man.

Beck LH Jr, Salant DJ.

J Clin Invest. 2014 Jun;124(6):2307-14. doi: 10.1172/JCI72270. Epub 2014 Jun 2. Review.

29.

Glomerular disease: looking beyond pathology.

Wiggins RC, Alpers CE, Holzman LB, He JC, Salant DJ, Chugh SS, Natarajan R, Trachtman H, Brasile L, Star RA, Rys-Sikora KE, Moxey-Mims MM, Flessner MF; Kidney Research National Dialogue.

Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1138-40. doi: 10.2215/CJN.01450214. Epub 2014 Apr 3.

30.

Introduction: Complement-mediated kidney diseases.

Salant DJ.

Semin Nephrol. 2013 Nov;33(6):477-8. doi: 10.1016/j.semnephrol.2013.08.010. No abstract available.

PMID:
24161034
31.

Anti-phospholipase A2 receptor antibodies and malignancy in membranous nephropathy.

Timmermans SA, Ayalon R, van Paassen P, Beck LH Jr, van Rie H, Wirtz JJ, Verseput GH, Frenken LA, Salant DJ, Cohen Tervaert JW; Limburg Renal Registry.

Am J Kidney Dis. 2013 Dec;62(6):1223-5. doi: 10.1053/j.ajkd.2013.07.019. Epub 2013 Sep 8. No abstract available.

PMID:
24021909
32.

Podocyte-specific deletion of signal transducer and activator of transcription 3 attenuates nephrotoxic serum-induced glomerulonephritis.

Dai Y, Gu L, Yuan W, Yu Q, Ni Z, Ross MJ, Kaufman L, Xiong H, Salant DJ, He JC, Chuang PY.

Kidney Int. 2013 Nov;84(5):950-61. doi: 10.1038/ki.2013.197. Epub 2013 Jul 10.

33.

Genetic variants in membranous nephropathy: perhaps a perfect storm rather than a straightforward conformeropathy?

Salant DJ.

J Am Soc Nephrol. 2013 Mar;24(4):525-8. doi: 10.1681/ASN.2013020166. Epub 2013 Mar 14. No abstract available.

34.

Inhibitory effects of Robo2 on nephrin: a crosstalk between positive and negative signals regulating podocyte structure.

Fan X, Li Q, Pisarek-Horowitz A, Rasouly HM, Wang X, Bonegio RG, Wang H, McLaughlin M, Mangos S, Kalluri R, Holzman LB, Drummond IA, Brown D, Salant DJ, Lu W.

Cell Rep. 2012 Jul 26;2(1):52-61. doi: 10.1016/j.celrep.2012.06.002. Epub 2012 Jul 12.

35.

Coexistence of ANCA-associated glomerulonephritis and anti-phospholipase A(2) receptor antibody-positive membranous nephropathy.

Surindran S, Ayalon R, Hasan N, Beck LH Jr, Salant DJ, Barisoni L, Skolnik EY, Beara-Lasic L.

Clin Kidney J. 2012 Apr;5(2):162-165. Epub 2012 Mar 9.

36.

IgG4-Related Disease Is Not Associated with Antibody to the Phospholipase A2 Receptor.

Khosroshahi A, Ayalon R, Beck LH Jr, Salant DJ, Bloch DB, Stone JH.

Int J Rheumatol. 2012;2012:139409. doi: 10.1155/2012/139409. Epub 2012 May 10.

37.

Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease.

George B, Verma R, Soofi AA, Garg P, Zhang J, Park TJ, Giardino L, Ryzhova L, Johnstone DB, Wong H, Nihalani D, Salant DJ, Hanks SK, Curran T, Rastaldi MP, Holzman LB.

J Clin Invest. 2012 Feb;122(2):674-92. doi: 10.1172/JCI60070. Epub 2012 Jan 17.

38.

Noninvasive assessment of antenatal hydronephrosis in mice reveals a critical role for Robo2 in maintaining anti-reflux mechanism.

Wang H, Li Q, Liu J, Mendelsohn C, Salant DJ, Lu W.

PLoS One. 2011;6(9):e24763. doi: 10.1371/journal.pone.0024763. Epub 2011 Sep 20.

39.

Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis.

Bollée G, Flamant M, Schordan S, Fligny C, Rumpel E, Milon M, Schordan E, Sabaa N, Vandermeersch S, Galaup A, Rodenas A, Casal I, Sunnarborg SW, Salant DJ, Kopp JB, Threadgill DW, Quaggin SE, Dussaule JC, Germain S, Mesnard L, Endlich K, Boucheix C, Belenfant X, Callard P, Endlich N, Tharaux PL.

Nat Med. 2011 Sep 25;17(10):1242-50. doi: 10.1038/nm.2491. Erratum in: Nat Med. 2011 Nov;17(11):1521. Nat Med. 2011 Oct;17(10):2 p following 1250.

40.

Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy.

Beck LH Jr, Fervenza FC, Beck DM, Bonegio RG, Malik FA, Erickson SB, Cosio FG, Cattran DC, Salant DJ.

J Am Soc Nephrol. 2011 Aug;22(8):1543-50. doi: 10.1681/ASN.2010111125. Epub 2011 Jul 22.

41.

Membranous nephropathy associated with IgG4-related disease.

Cravedi P, Abbate M, Gagliardini E, Galbusera M, Buelli S, Sabadini E, Marasà M, Beck LH Jr, Salant DJ, Benigni A, D'Agati V, Remuzzi G.

Am J Kidney Dis. 2011 Aug;58(2):272-5. doi: 10.1053/j.ajkd.2011.05.002. Epub 2011 Jun 12.

PMID:
21658826
42.

Anti-phospholipase A2 receptor antibody in membranous nephropathy.

Qin W, Beck LH Jr, Zeng C, Chen Z, Li S, Zuo K, Salant DJ, Liu Z.

J Am Soc Nephrol. 2011 Jun;22(6):1137-43. doi: 10.1681/ASN.2010090967. Epub 2011 May 12.

43.

Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy.

Hofstra JM, Beck LH Jr, Beck DM, Wetzels JF, Salant DJ.

Clin J Am Soc Nephrol. 2011 Jun;6(6):1286-91. doi: 10.2215/CJN.07210810. Epub 2011 Apr 7.

44.

The fate of Notch-deficient nephrogenic progenitor cells during metanephric kidney development.

Bonegio RG, Beck LH, Kahlon RK, Lu W, Salant DJ.

Kidney Int. 2011 May;79(10):1099-112. doi: 10.1038/ki.2010.553. Epub 2011 Jan 26.

45.

Targeting complement C5 in atypical hemolytic uremic syndrome.

Salant DJ.

J Am Soc Nephrol. 2011 Jan;22(1):7-9. doi: 10.1681/ASN.2010111145. Epub 2010 Dec 2. No abstract available.

46.

Goodpasture's disease--new secrets revealed.

Salant DJ.

N Engl J Med. 2010 Jul 22;363(4):388-91. doi: 10.1056/NEJMe1006301. No abstract available.

PMID:
20660408
47.

Blockade of the kinin B1 receptor ameloriates glomerulonephritis.

Klein J, Gonzalez J, Decramer S, Bandin F, Neau E, Salant DJ, Heeringa P, Pesquero JB, Schanstra JP, Bascands JL.

J Am Soc Nephrol. 2010 Jul;21(7):1157-64. doi: 10.1681/ASN.2009090887. Epub 2010 May 6.

48.

Methylation determines fibroblast activation and fibrogenesis in the kidney.

Bechtel W, McGoohan S, Zeisberg EM, Müller GA, Kalbacher H, Salant DJ, Müller CA, Kalluri R, Zeisberg M.

Nat Med. 2010 May;16(5):544-50. doi: 10.1038/nm.2135. Epub 2010 Apr 25.

49.

Membranous nephropathy: recent travels and new roads ahead.

Beck LH Jr, Salant DJ.

Kidney Int. 2010 May;77(9):765-70. doi: 10.1038/ki.2010.34. Epub 2010 Feb 24. Review.

50.

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ.

N Engl J Med. 2009 Jul 2;361(1):11-21. doi: 10.1056/NEJMoa0810457.

Supplemental Content

Loading ...
Support Center